Skip to main content
Clinical Trials/CTRI/2018/04/013504
CTRI/2018/04/013504
Completed
未知

An exploratory study to investigate cleanser formulations for their efficacy on Skinimperfections (acne and skin respect) through instrumental and dermatologist assessment,over a 4 week daily home usage

Oreal India Pvt Ltd0 sites152 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Oreal India Pvt Ltd
Enrollment
152
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 3, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Oreal India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy female Indian volunteers, aged 18 â?? 45 years (both inclusive)
  • 2\. Subjects with casual sebum levels \>\= 80 μg/cm2 and Sebum Excretion Rate \>\= 50 μg/cm2
  • 3\. Subjects having atleast 5 inflammatory and no more than 15 inflammatory lesions over
  • the whole face, out of which atleast 2 are papules of size \> 0\.5 mm and evolved in last
  • 5 days (basis the medical history)
  • 4\. Subjects having at least 10 non\-inflammatory acne lesions and not more than 50 non\-inflammatory acne lesions over the whole face, out of which at least 50% are open comedones (black heads)
  • 5\. Subjects with medium to dark skin color having ITA values between \>\= 10 and \<\= 41
  • 6\. Subjects having at least two Post Inflammatory Hyper pigmentation spots of size 3 mm or more
  • 7\. Subjects with adequate representation of normal and sensitive skin
  • 8\. Females with a stable hormonal status, as self\-declared by subjects

Exclusion Criteria

  • 1\. Known hypersensitivity to any of the study products or constituents
  • 2\. Any significant skin pathology in the test area, like rosacea, severe acne, or eczema
  • 3\. Subjects on any topical or systemic treatment that could interfere with the study
  • treatments/assessments (topical benzoyl peroxide and other anti\-acne or anti\-seborreic
  • products, antibiotics, corticosteroids, retinoids, anti\-inflammatory drugsâ?¦) within the
  • last 4 weeks prior to participation in the study, and during the study
  • 4\. Subjects who are having chronic illness or had major surgery in the last year
  • 5\. Subject with any significant medical condition that would interfere with the
  • participation in the trial
  • 6\. Subject who are allergic or sensitive to bar cleansing products/face cleansers/

Outcomes

Primary Outcomes

Not specified

Similar Trials